Loading clinical trials...
Loading clinical trials...
A Phase III Study of Marimastat in Patients With Small Cell Lung Cancer Following a Response to First Line Chemotherapy
Conditions
Interventions
marimastat
Placebo
Locations
38
Canada
Cross Cancer Institute
Edmonton, Alberta, Canada
Penticton Regional Hospital
Penticton, British Columbia, Canada
British Columbia Cancer Agency
Vancouver, British Columbia, Canada
British Columbia Cancer Agency - Vancouver Island Cancer Centre
Victoria, British Columbia, Canada
CancerCare Manitoba
Winnipeg, Manitoba, Canada
Moncton Hospital
Moncton, New Brunswick, Canada
Start Date
January 31, 1997
Primary Completion Date
February 13, 2001
Completion Date
December 15, 2008
Last Updated
April 3, 2020
NCT07177937
NCT05671510
NCT06043817
NCT06426511
NCT06498635
NCT03563976
Lead Sponsor
NCIC Clinical Trials Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions